MYND Life Sciences (MYNDF, $0.06) was one of the top gainers for the month, rising +3 to $0.06 per share. A.I.dvisor analyzed 852 stocks in the Biotechnology Industry for the month ending March 20, 2025 and discovered that of them (3) exhibited an Uptrend while of them (6) exhibited a Downtrend.